デフォルト表紙
市場調査レポート
商品コード
1619305

心臓ペースメーカー市場規模、シェア、成長分析、タイプ別、エンドユーザー別、地域別 - 産業別予測、2024~2031年

Cardiac Pacemaker Market Size, Share, Growth Analysis, By Type (External Pacemakers, Implantable Pacemakers), By End User (Hospitals, Cardiac Clinics), By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.96円
心臓ペースメーカー市場規模、シェア、成長分析、タイプ別、エンドユーザー別、地域別 - 産業別予測、2024~2031年
出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心臓ペースメーカーの世界市場規模は2022年に39億2,000万米ドルと評価され、2023年の40億4,000万米ドルから2031年には51億6,000万米ドルに成長し、予測期間(2024-2031年)のCAGRは3.1%で成長する見通しです。

世界の心臓ペースメーカー市場は、心血管疾患の有病率の上昇と高齢化によって大きな成長を遂げています。ライフスタイルの変化などの要因が心臓疾患のリスクをさらに高めています。技術の革新的な進歩により、遠隔監視機能と自動生理学的調整を特徴とする小型のワイヤレスペースメーカーが開発されています。早期診断に対する意識の高まりや新興国市場におけるヘルスケアインフラの充実も市場拡大に寄与しています。さらに、研究開発への投資が活発化し、機器メーカーとヘルスケアプロバイダーとの協力関係も成長を刺激しています。しかし、移植コストの高さや遠隔地でのアクセス制限といった課題が、市場の成長を妨げる可能性もあります。全体的には、継続的な技術革新と低侵襲手術へのシフトにより、市場は大幅な成長を遂げると思われます。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2023年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 技術の進歩
  • ケーススタディ
  • 貿易分析

心臓ペースメーカー市場規模:タイプ別

  • 市場概要
  • 体外ペースメーカー
    • シングルチャンバー
    • デュアルチャンバー
  • 埋め込み型ペースメーカー
    • 従来型
    • リードレス

心臓ペースメーカー市場規模:エンドユーザー別

  • 市場概要
  • 病院
  • 心臓クリニック
  • 外来手術センター
  • その他

心臓ペースメーカー市場規模:地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2023年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2021-2023)

主要企業プロファイル

  • Medtronic PLC
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Lepu Medical Technology Co., Ltd.
  • LivaNova PLC
  • Osypka AG
  • Oscor Inc.
  • Pacetronix
  • Medico S.R.L.
  • MicroPort Scientific Corporation
  • Shree Pacetronix Ltd.
  • ZOLL Medical Corporation
  • Asahi Kasei Corporation
  • OSYPKA Medical GmbH
  • Cardiac Science Corporation
  • EBR Systems, Inc.
  • BioTrace Medical, Inc.
  • Sorin Group(LivaNova)
  • Vitatron(Medtronic)

結論と推奨事項

目次
Product Code: SQMIG35A2302

Global Cardiac Pacemaker Market size was valued at USD 3.92 billion in 2022 and is poised to grow from USD 4.04 billion in 2023 to USD 5.16 billion by 2031, growing at a CAGR of 3.1% during the forecast period (2024-2031).

The Global Cardiac Pacemaker Market is witnessing significant growth, driven by the rising prevalence of cardiovascular diseases and an aging population. Factors such as lifestyle changes are further escalating the risk of heart issues. Innovative advancements in technology have led to the development of smaller, wireless pacemakers featuring remote monitoring capabilities and automatic physiological adjustments. Increased awareness of early diagnosis and enhancements in healthcare infrastructure in developing regions also contribute to market expansion. Additionally, heightened investment in research and development, along with collaborations between device manufacturers and healthcare providers, is stimulating growth. However, challenges like high implantation costs and limited access in remote areas may hinder progress. Overall, the market is set for substantial growth due to ongoing innovations and a shift towards minimally invasive procedures.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Pacemaker market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Pacemaker Market Segmental Analysis

Global Cardiac Pacemaker Market is segmented by type, end user and region. Based on type, the market is segmented into external pacemakers and implantable pacemakers. Based on end user, the market is segmented into hospitals, cardiac clinics, ambulatory surgery centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Pacemaker Market

One of the primary factors propelling the Global Cardiac Pacemaker Market is the rising prevalence of cardiovascular diseases. As the occurrence of heart-related issues such as arrhythmias and heart failure escalates around the world, the demand for cardiac pacemakers to effectively manage and treat these ailments intensifies. This trend is further exacerbated by lifestyle factors such as sedentary behavior, poor dietary choices, and an aging demographic, all of which collectively increase the incidence and burden of cardiovascular diseases globally. Consequently, the heightened need for innovative cardiac solutions significantly drives market growth and expansion.

Restraints in the Global Cardiac Pacemaker Market

A significant constraint within the Global Cardiac Pacemaker market is the elevated expenses linked to pacemaker implantation procedures. These advanced medical devices necessitate expertise from trained medical professionals along with specialized equipment and comprehensive post-operative care. The cumulative costs-including the pacemaker itself, surgical expenses, hospitalization, and subsequent follow-up-can be quite high, imposing a heavy financial strain on many patients. This economic hurdle limits access to essential cardiac care, especially for individuals in lower-income areas or those lacking sufficient insurance coverage, ultimately hindering the overall growth of the market.

Market Trends of the Global Cardiac Pacemaker Market

A prominent trend in the Global Cardiac Pacemaker Market is the rising adoption of remote monitoring technologies. This shift is fueled by the demand for continuous patient oversight and the urgent need for early detection of device malfunctions and abnormalities. Remote monitoring solutions allow healthcare providers to assess and track pacemaker performance in real-time, significantly improving patient care through timely interventions and minimizing the necessity for frequent hospital visits. The integration of advanced communication technologies and wireless connectivity has streamlined data transmission, enhancing patient outcomes and engagement. As a result, remote monitoring is becoming an essential feature in cardiac care strategies, shaping the future landscape of the market.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Case Studies
  • Trade Analysis

Global Cardiac Pacemaker Market Size by Type & CAGR (2024-2031)

  • Market Overview
  • External Pacemakers
    • Single Chamber
    • Dual Chamber
  • Implantable Pacemakers
    • Conventional
    • Leadless

Global Cardiac Pacemaker Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Hospitals
  • Cardiac Clinics
  • Ambulatory Surgery Centers
  • Others

Global Cardiac Pacemaker Market Size & CAGR (2024-2031)

  • North America (Type, End User)
    • US
    • Canada
  • Europe (Type, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Medtronic PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronik SE & Co. KG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lepu Medical Technology Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Osypka AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oscor Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pacetronix
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medico S.R.L.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shree Pacetronix Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ZOLL Medical Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Asahi Kasei Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OSYPKA Medical GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardiac Science Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EBR Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioTrace Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sorin Group (LivaNova)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vitatron (Medtronic)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations